GLI1 and mastocytosis: Homeostatic GLI function, modulated in cultures mainly by non-canonical pathways, controls p53 function and KIT expression, resulting in suppression of apoptosis and promoting proliferation of mast cells, thus contributing to mast cell number maintenance in steady-state and possibly in disease conditions with mast cell-related presentations, as shown in mastocytosis (16).